Health Tip: More Reasons to Quit Smoking
(HealthDay News) — As soon as you quit smoking, you begin to reduce your risk of cancer, heart disease, lung disease and stroke.
Month: April 2012
Malians queue for fuel as anti-junta sanctions begin
BAMAKO (Reuters) – Malians queued to stock up on petrol at garages around the capital Bamako on Tuesday after neighbors launched trade and diplomatic sanctions aimed at forcing the military junta to hand over power. For long one of the most stable democracies in West Africa, Mali has plunged into turmoil since a widely condemned March 22 coup that emboldened Tuareg rebels to seize half the country in their quest for a northern homeland. …
Chocolate, a health food?
Recent scientific studies by Yale professors suggest that limited doses of chocolate may confer significant health benefits. "I do think it is a health food, I think it's a food you can love that loves you back and I think if you get the dose right, …
See all stories on this topic »
Bethany council approves exercise concessions at beach, boardwalk
BETHANY BEACH — Two new exercise concessions will be offered at the Bethany Beach Bandstand this summer. While a schedule has not yet been finalized, the Town Council approved the operation of tai chi, Zumba and yoga classes on the beach and bandstand …
See all stories on this topic »
NATO-Russia Exercise Tests Responses to…
This was the fictitious scenario for a counter-terrorism tabletop exercise organized under the NRC, at NATO Headquarters on 26 and 27 March 2012. According to the scenario, the NRC discussed their shared concerns about the situation and tasked experts …
See all stories on this topic »
Running: Regular exercise perfect way to maintain weight
However, after I reached my goal weight, it became apparent that I needed to incorporate considerably more exercise into my life if I wanted to keep the weight off. Sure, you can maintain your weight loss by controlling calories, but as we age we lose …
See all stories on this topic »
Minera IRL Directors' Dealing and Exercise of Options
Application has been made for the 2230000 new ordinary shares created as the result of option exercises to be admitted to trading on AIM. Trading is expected to begin on 9 April 2012. Following the admission of the new shares to trading, …
See all stories on this topic »
Obama takes on Republicans over tax fairness
WASHINGTON (Reuters) – President Barack Obama, seizing on Republican plans to slash deficits that the White House sees as a potent vote winner for Democrats in this year’s election, slammed his opponents on Tuesday to reinforce his claim that they favor the rich. In a week in which Republican Mitt Romney is expected to extend his lead in the race for his party’s nomination to confront Obama in the November 6 election, the president took aim at their recent budget plans to cut spending and taxes. “This congressional Republican budget … it’s a Trojan horse. …
Why FDA Declines to Ban BPA
NASA’s Spacecraft Captures a Massive Solar Tornado on Film
Olympus may try to tough out scandal without help
TOKYO (Reuters) – Japan’s Olympus Corp may be able to recover from a huge accounting scandal without having to bring in new investors, even as it looks to beef up its capital by around $3 billion over the longer term, its likely new president said on Tuesday. The maker of medical equipment and cameras has been badly weakened by the $1.7 billion fraud, one of Japan’s worst corporate scandals, which has put the company under pressure to raise fresh equity to put its finances on a more stable footing. …
GSK says new data support filing of diabetes drug
LONDON (Reuters) – GlaxoSmithKline will push ahead with plans to file its experimental once-weekly diabetes drug albiglutide for regulatory approval, following the read-out from a series of clinical trials. Albiglutide belongs to the same class of injectable GLP-1 medicines as Novo Nordisk’s Victoza and Byetta, from Amylin Pharmaceuticals and Eli Lilly. Byetta was the first drug of the type. Last November, GSK reported that albiglutide cut blood sugar less than daily Victoza in the first of a series of late-stage clinical trials, dimming its prospects in an increasingly competitive market. …